Contains berberine — check your medicines before ordering
HomeBlog › Berberine & CYP450 Enzyme Inhibition, Explained
⚠️ Safety Notes

Berberine & CYP450 Enzyme Inhibition, Explained

2026 guide  •  6 min read

Short answer: Berberine inhibits several cytochrome P450 liver enzymes — CYP3A4, CYP2D6 and CYP2C9 — along with the P-glycoprotein transporter, three specifically named liver pathways involved in clearing many common medicines.

What CYP450 enzymes normally do

These liver enzymes break down and clear a large share of prescription medicines from your bloodstream — when their activity is inhibited, those medicines can build up to higher-than-intended levels.

Why three named enzymes matters more than a vague "liver interaction"

Naming CYP3A4, CYP2D6 and CYP2C9 specifically lets a pharmacist check your exact medications against these particular pathways — far more useful than a generic caution.

💊 Worth knowing: the P-glycoprotein transporter is a separate, additional pathway berberine also affects — worth mentioning specifically when discussing this with a pharmacist.

Why this mechanism explains the formula's whole safety section

Documented concerns with diabetes medicines, warfarin, cyclosporine, statins, and blood pressure and heart medicines all trace back to this same enzyme-inhibition mechanism.

Check the packages

60-day guarantee advertised — confirm terms at checkout.

See Packages
Lowest per bottle: $49